This week, I’ve been reporting on some common health issues men face as they get older. And today, I’m talking specifically about prostate cancer—which will strike one out of every nine men at some point in their lives.
Thankfully, a new screening tool being developed in the U.K. could help men make a more informed decision about which treatment approach may work best for them. More on that tool in just a moment.
Of course, the cancer industry remains stuck in the 1980s, relying on the deeply flawed prostate specific antigen (PSA) screening test that’s wrong about 75 percent of the time! Granted, the test was only designed to monitor cancer progression in men already diagnosed with prostate cancer. And it was never meant to be used as a routine screening test for all men.
But despite its clear shortcomings, many doctors still rely on PSA results to justify invasive biopsies and aggressive treatments of slow-growing tumors that don’t really pose a threat. In fact, most prostate tumors grow so slowly, they never invade adjacent tissues, nor spread to distant parts of the body. Which is why many men who reach older ages die with prostate cancer—not because of it.
I’m of the opinion that most men diagnosed with the typical, slow-growing type of prostate cancer should practice “watchful waiting.” Which means you and your doctor actively monitor the condition before rushing into painful, invasive, disfiguring, and disabling urological procedures and surgery.
But even “watchful waiting” has its drawbacks…
In fact, men who choose that route may still undergo monitoring that may include blood testing, digital rectal exams, magnetic resonance imaging (MRI) scans, and even painful, disabling surgical biopsies. So, while preferable over immediate radical treatment, these invasive and uncomfortable monitoring procedures often lead men to eventually “throw in the towel” and opt for drastic surgical treatment. (Of course, urologists are happy to provide it, even when they aren’t sure it’s really needed.)
But as I mentioned above, I’ve just learned about a new screening tool that may one day become a helpful, reliable part of this watchful waiting approach…
PUR urine test helps identify aggressive tumors
A new prostate urine risk (PUR) test uses genetic markers to identify men who are less likely to need radical treatments during the five years following prostate cancer diagnosis. It also helps identify men who might actually need more aggressive treatment five years sooner than current tests.
So, this new, easy, non-invasive, urine test could really give men a much more accurate snapshot of their own personalized risk and help them decide on a suitable course of action (or inaction).
Unfortunately, it may take a while before this test makes its way through regulatory red tape into mainstream medical treatment. When it does, you’ll be the first to hear about it—right here in my Daily Dispatch or in my monthly newsletter, Insiders’ Cures. (Not yet a subscriber? No problem…all it takes is one click!)
In the meantime, it’s important to focus on what you can do right now to prevent prostate problems. And you can learn everything you need to know about how to NATURALLY conquer prostate cancer, banish an enlarged prostate, and maximize your manhood, in my new comprehensive, science-backed Insider’s Ultimate Guide to Perfect Prostate Health. This protocol also explains all the steps involved in “watchful waiting” or “active surveillance.” To learn more about this innovative learning protocol, or to sign up today, click here now!
“New Urine Test May Show Whether Prostate Cancer Needs Treatment.” Newsmax, 6/26/19. (newsmax.com/health/health-news/prostate-cancer-mens-health-study/2019/06/26/id/922131/)